The University of California San Francisco (UCSF) Amyloid Heart Disease Program provides comprehensive, patient-centered care for all forms of cardiac amyloidosis. They are committed to offering access to state-of-the-art approaches for both diagnosis and treatment. To accomplish this, they routinely participate in clinical trials and expanded access programs for the most promising therapies. Patients are followed closely by nurses and pharmacists in the UCSF Heart Failure Clinic to help manage symptoms of heart failure and maintain the best quality of life possible.

Effective treatment of amyloidosis requires a multidisciplinary team. As part of the UCSF Amyloid Center, they work closely with other amyloid specialists from hematology-oncology, neurology, liver transplant, nephrology, radiology, pathology, and more to offer patients the integrated treatment they need. The center serves as a resource for the support of patients, family members and caregivers. 

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Sandy W. Wong, MD

Cardiology:
Van Selby, MD; Teresa De Marco, MD

Nephrology:
Kerry Cho, MD, FACP